Format

Send to

Choose Destination
Eur J Cardiothorac Surg. 2012 Mar;41(3):696-8. doi: 10.1093/ejcts/ezr038.

Tricuspid transcatheter valve-in-valve: an alternative for high-risk patients.

Author information

1
Department of Cardiovascular Surgery, Federal University of São Paulo, São Paulo, Brazil. drgaia@terra.com.br

Abstract

Tricuspid valve disease is not uncommon. Some patients with tricuspid valve disease require tricuspid replacement with bioprosthesis and, over time, may require re-interventions. Transcatheter tricuspid valve-in-valve approach has emerged as an alternative to treat dysfunctional bioprosthesis. In this article, we report a case of a patient with four previous cardiac interventions presenting with tricuspid bioprosthesis dysfunction. The patient was treated with the transcatheter transatrial tricuspid valve-in-valve procedure. The procedure was successful with no residual leakage and a non-significant mean gradient. The patient recovered well and was discharged in 1 week. The procedure is a feasible alternative for high-risk patients. Selection and postoperative care are crucial for the outcome.

PMID:
22345189
DOI:
10.1093/ejcts/ezr038
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center